The MARIA research reactor (Poland) has added additional operating days, which has helped to reduce the loss of HFR production capacity.

The MARIA research reactor in Poland has added additional operating days, which has helped to reduce the loss of HFR production capacity.


February 18, 2022 — The Nuclear Medicine Europe (NMEu) Emergency Response Team held a call on February 14 on the unplanned HFR outage that resulted in cancellation of the planned HFR first operating cycle of 2022. NMEu was told that the HFR reactor operator, NRG, has a plan to restart the reactor that is being reviewed by their Reactor Safety Committee before submission to the Dutch nuclear safety authority, ANVS, later this week. NRG is aiming to restart the HFR reactor on March 17 for its second cycle of 2022, noting that the licensing and execution of restoring the cooling function must still be performed.

Fortunately, the MARIA research reactor (Poland) has added additional operating days, which has helped to reduce the loss of HFR production capacity. The BR2 reactor also resumed operations February 12—three days earlier than originally planned. Curium has harvested Mo-99 targets from short irradiations at BR2 and is now processing Mo-99 for customers. IRE will resume production on its high-enriched uranium production line later this week. Read the full notice here.

For more information: www.snmmi.org

Related Content:

Update on Unplanned Outage of the HFR Reactor

SNMMI Issues Alert That HFR Outage Will Impact Isotope Supply

NorthStar Medical Radioisotopes Advances Focus on Therapeutic and Specialized SPECT Radiopharmaceuticals

How Nuclear Fusion is Revolutionizing Medical Isotope Production

FDA Approves Additional Molybdenum-99 (Mo-99) Filling Lines at NorthStar Medical Radioisotopes

Medical Isotope Industry Opposes Export of Highly Enriched Uranium for IRE

IBA and NorthStar Medical Radioisotopes Expand Collaboration to Enable Global Availability of Tc-99m

 

 


Related Content

Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
News | SNMMI

September 18, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI), as a professional society ...

Time September 18, 2023
arrow
News | PET-CT

September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...

Time September 08, 2023
arrow
Feature | PET Imaging

According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...

Time September 05, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 31, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time August 31, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 29, 2023 — Mammograms are an essential part of preventive healthcare, and when an initial review reveals a ...

Time August 29, 2023
arrow
News | Radiation Therapy

August 23, 2023 — RefleXion Medical, a therapeutic oncology company, today announced that the first patient has ...

Time August 23, 2023
arrow
News | Contrast Media

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Time August 17, 2023
arrow
Subscribe Now